Pinpointing the tumor-specific T cells via TCR clusters

Area of Science:

• Immunology
• Oncology
• Bioinformatics

Background:

• Adoptive cell transfer (ACT) is a key cancer immunotherapy strategy.
• ACT efficacy relies on enriching tumor-specific T cells in the graft.
• Current methods for assessing T cell enrichment are laborious and limited.

Purpose of the Study:

• To develop a rapid and efficient method for assessing tumor-specific T cell receptor (TCR) enrichment.
• To optimize T cell culturing conditions for enhanced ACT therapy.
• To identify surface markers for T cell enrichment in tumor-infiltrating lymphocytes (TILs).

Main Methods:

• Homology cluster analysis of TCR repertoires to identify tumor-reactive TCRs.
• Assessment of TCR presence within TILs.
• Optimization of TIL culturing using cytokine and antibody combinations (IL-2low/IL-21/anti-PD-1).
• Investigation of surface marker expression (PD-1, CD39, 4-1BB) for T cell enrichment.

Main Results:

• Homology cluster analysis successfully identified tumor-reactive TCRs.
• Optimized culturing conditions (IL-2low/IL-21/anti-PD-1) enhanced TIL efficiency.
• Confirmed enrichment of tumor-targeting T cells using surface markers like CD4+ PD-1+/CD39+ and CD8+ PD-1+/CD39+ in TILs.
• Demonstrated enrichment in 4-1BB-sorted cells from re-stimulated TILs.

Conclusions:

• Homology cluster analysis provides a rapid assessment of tumor-specific TCR enrichment.
• This approach accelerates the development of T cell-based therapies.
• Optimized culturing and marker-based enrichment strategies enhance ACT efficacy.